DermTech, Inc. Common Stock
DMTK
DMTK was delisted on the 26th of June, 2024.
22 hedge funds and large institutions have $106M invested in DermTech, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
5% more funds holding
Funds holding: 21 → 22 (+1)
3% less capital invested
Capital invested by funds: $109M → $106M (-$2.8M)
57% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MSU
Mizuho Securities USA
New York
|
+$8.34M |
| 2 |
WCMNY
Westchester Capital Management (New York)
Valhalla,
New York
|
+$3.43M |
| 3 |
CI
Cowen Inc
New York
|
+$1.84M |
| 4 |
CFIC
City Financial Investment Company
London,
United Kingdom
|
+$994K |
| 5 |
BCM
Basso Capital Management
Stamford,
Connecticut
|
+$547K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFM
Boothbay Fund Management
New York
|
-$5.92M |
| 2 |
HIM
HGC Investment Management
Toronto,
Ontario, Canada
|
-$4.95M |
| 3 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$2.98M |
| 4 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
-$2.12M |
| 5 |
6CM
683 Capital Management
New York
|
-$1.78M |
DMTK Hedge Fund Activity: Q2 2018 in Review
22 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in DermTech, Inc. Common Stock (DMTK) for Q2 2018, worth a combined $106M — down 2.6% from $109M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new DMTK positions and 2 closed out — a net gain of 1 holder — while 3 added to existing stakes and 7 trimmed.
The largest buyer was Mizuho Securities USA, adding an estimated $8.34M. The largest seller was Boothbay Fund Management, exiting entirely with an estimated $5.92M sold.
- 22 institutional investors held DermTech, Inc. Common Stock (DMTK) as of Q2 2018, up from 21 in Q1 2018.
- Funds reported $106M of DermTech, Inc. Common Stock stock for Q2 2018, down 2.6% quarter-over-quarter.
- 3 funds opened new DermTech, Inc. Common Stock positions in Q2 2018 and 2 closed out, a net change of +1 holder.
- The largest DermTech, Inc. Common Stock buyer in Q2 2018 was Mizuho Securities USA, an estimated $8.34M added.
- The largest DermTech, Inc. Common Stock seller in Q2 2018 was Boothbay Fund Management, an estimated $5.92M sold.
Based on aggregated 13F filings for Q2 2018.